Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03212157 : GlucoCEST MRI in Oncology
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Healthy Volunteers:

1. No previous history of cancer

2. No known renal impairment or an eGFR within a standard reference value if there
is a history of renal disease.

3. Aged 18 or over with capacity to consent.

- Patient groups:

1. Confirmed diagnosis of selected cancer types (head and neck, lymphoma and glioma)

2. No known renal impairment or an eGFR within a standard reference value if there
is a history of renal disease

3. Aged 18 or over with capacity to consent.

Exclusion Criteria:

- For both groups:

1. Confirmed diagnosis of selected cancer types (head and neck, lymphoma and glioma)

2. Pregnancy

3. Contradiction to MRI magnetic field (pacemaker, metallic implant, severe
claustrophobia, etc)

4. Allergy to MR contrast agent (Gadolinium)

5. Adult with Impaired capacity

6. Deranged renal function with eGFR
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03212157      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740